European Cystic Fibrosis Society

June 16, 2016June 16, 2016

Promising Results of Kalydeco and Orkambi for Cystic Fibrosis Presented at European CF Conference

News

Vertex Pharmaceuticals scientists presented positive results from clinical studies evaluating Kalydeco (ivacaftor) and Orkambi (lumacaftor/ivacaftor) at the 39th European Cystic Fibrosis Society (ECFS) Conference June 8-11 in Basel, Switzerland. The presentations included real-world data from ... Read more

June 12, 2015November 5, 2015

Vertex Presents Data at European Cystic Fibrosis Society (ECFS) Conference on Orkambi Combo Therapy

Cystic Fibrosis, News

Vertex Pharmaceuticals recently announced results from its PROGRESS long-term extension trial that is evaluating the efficacy of the ORKAMBI (lumacaftor/ivacaftor) investigational regimen in patients with cystic fibrosis (CF). Cystic Fibrosis patients aged ... Read more